Immunogenicity and antigenicity of allogeneic amniotic epithelial transplants grafted to the cornea, conjunctiva, and anterior chamber.

PURPOSE To determine the immunogenic characterization of amniotic epithelium (AE), by examining the fate of allogeneic AE grafts heterotopically transplanted in the eye. METHODS Intact AE from enhanced green fluorescence protein (EGFP) transgenic mice (C57BL/6 background) and wild-type C57BL/6 mice were transplanted onto cornea or conjunctiva, or inserted into the anterior chamber (AC) of normal BALB/c mice, C57BL/6 mice, or BALB/c mice presensitized to donor antigens. For repeated AE transplantation experiments, AE was grafted in the other eye 7 days after the first grafting. Graft fate was assessed clinically and histologically at selected intervals after grafting. Infiltrating inflammatory cells were examined immunohistochemically. Sensitization to alloantigens by AE was assessed by the delayed hypersensitivity (DH) response. RESULTS In normal recipients, GFP+ cells were absent in EGFP donor-derived AE grafts by day 21 on cornea and by day 7 on conjunctiva. AE grafts implanted in the AC survived for >8 weeks. In presensitized recipients and recipients that underwent repeated AE implantation, graft survival was markedly shorter than in normal recipients. DH was induced at 2 weeks, but failed to be induced at 4 weeks after grafting on cornea or at 8 weeks after grafting on conjunctiva and in the AC of normal recipients. CONCLUSIONS Fresh allogeneic AE expressed immunogenicity when placed on the ocular surface, although no memory of allospecific DH was acquired. Allogeneic AE is clearly vulnerable to immune rejection in specifically sensitized recipients.

[1]  T. Oshika,et al.  Topical application of culture supernatant from human amniotic epithelial cells suppresses inflammatory reactions in cornea. , 2005, Experimental eye research.

[2]  J. McCulley,et al.  Immunosuppressive factors secreted by human amniotic epithelial cells. , 2005, Investigative ophthalmology & visual science.

[3]  J. Streilein Ocular immune privilege: therapeutic opportunities from an experiment of nature , 2003, Nature Reviews Immunology.

[4]  H. Klassen,et al.  Neural Progenitor Cells Lack Immunogenicity and Resist Destruction as Allografts , 2003, Stem cells.

[5]  D. Skelton,et al.  The enhanced green fluorescent protein (eGFP) is minimally immunogenic in C57BL/6 mice , 2001, Gene Therapy.

[6]  T. Hahn,et al.  Amniotic Membrane Transplantation in Infectious Corneal Ulcer , 2001, Cornea.

[7]  J. Streilein,et al.  Dynamics of donor cell persistence and recipient cell replacement in orthotopic corneal allografts in mice. , 2001, Investigative ophthalmology & visual science.

[8]  M. Usui,et al.  Immunogenicity of human amniotic membrane in experimental xenotransplantation. , 2001, Investigative ophthalmology & visual science.

[9]  D. Azar,et al.  Amniotic membrane inlay and overlay grafting for corneal epithelial defects and stromal ulcers. , 2001, Archives of ophthalmology.

[10]  S. Tseng,et al.  Suppression of interleukin 1α and interleukin 1β in human limbal epithelial cells cultured on the amniotic membrane stromal matrix , 2001 .

[11]  S. Tseng,et al.  Suppression of interleukin 1alpha and interleukin 1beta in human limbal epithelial cells cultured on the amniotic membrane stromal matrix. , 2001, The British journal of ophthalmology.

[12]  C. Lohmann,et al.  Hypopyon after repeated transplantation of human amniotic membrane onto the corneal surface. , 2000, Ophthalmology.

[13]  R. J. Mack,et al.  Amniotic membrane transplantation for acute chemical or thermal burns. , 2000, Ophthalmology.

[14]  D. H. Ma,et al.  Identification of Antiangiogenic and Antiinflammatory Proteins in Human Amniotic Membrane , 2000, Cornea.

[15]  B. Na,et al.  Amniotic membrane patching promotes healing and inhibits proteinase activity on wound healing following acute corneal alkali burn. , 2000, Experimental eye research.

[16]  S. Tseng,et al.  Amniotic membrane transplantation for symptomatic bullous keratopathy. , 1999, Archives of ophthalmology.

[17]  F. Kruse,et al.  Multilayer amniotic membrane transplantation for reconstruction of deep corneal ulcers. , 1999, Ophthalmology.

[18]  S. Tseng,et al.  Suppression of transforming growth factor‐beta isoforms, TGF‐β receptor type II, and myofibroblast differentiation in cultured human corneal and limbal fibroblasts by amniotic membrane matrix , 1999 .

[19]  H. Dua Amniotic membrane transplantation , 1999, The British journal of ophthalmology.

[20]  S. Tseng,et al.  Amniotic membrane transplantation with or without limbal allografts for corneal surface reconstruction in patients with limbal stem cell deficiency. , 1998, Archives of ophthalmology.

[21]  A. Kumar,et al.  Apoptosis and Fas expression in human fetal membranes. , 1998, The Journal of clinical endocrinology and metabolism.

[22]  Tomoko Nakanishi,et al.  ‘Green mice’ as a source of ubiquitous green cells , 1997, FEBS letters.

[23]  S. Tseng,et al.  Amniotic membrane transplantation for persistent epithelial defects with ulceration. , 1997, American journal of ophthalmology-glaucoma.

[24]  A. Ziegler,et al.  Amnion Epithelial Cells, in Contrast to Trophoblast Cells, Express All Classical HLA Class I Molecules Together With HLA‐G , 1997, American journal of reproductive immunology.

[25]  K. Tsubota,et al.  Surgical reconstruction of the ocular surface in advanced ocular cicatricial pemphigoid and Stevens-Johnson syndrome. , 1996, American journal of ophthalmology.

[26]  T. Reynolds,et al.  T–cell mediated rejection of gene–modified HIV–specific cytotoxic T lymphocytes in HIV–infected patients , 1996, Nature Medicine.

[27]  K. Tsubota,et al.  SURGICAL RECONSTRUCTION OF THE OCULAR SURFACE IN ADVANCED OCPAND SJS , 1996 .

[28]  S. Tseng,et al.  Transplantation of Preserved Human Amniotic Membrane for Surface Reconstruction in Severely Damaged Rabbit Corneas , 1995, Cornea.

[29]  J. Pepose,et al.  T-cell mediated responses in a murine model of orthotopic corneal transplantation. , 1995, Investigative ophthalmology & visual science.

[30]  J. Streilein,et al.  ORTHOTOPIC CORNEAL TRANSPLANTATION IN MICE—EVIDENCE THAT THE IMMUNOGENETIC RULES OF REJECTION DO NOT APPLY , 1992, Transplantation.

[31]  D. Easty,et al.  Effect of mismatches for major histocompatibility complex and minor antigens on corneal graft rejection. , 1991, Investigative ophthalmology & visual science.

[32]  Y. Finkelstein,et al.  Antibacterial properties of human amniotic membranes. , 1991, Placenta.

[33]  J. Fishback,et al.  Amnion membrane epithelial cells express class I HLA and contain class I HLA mRNA. , 1988, Journal of immunology.

[34]  R. Larkin,et al.  THE EFFECT OF REPEATED PREGNANCIES ON RENAL ALLOGRAFT FUNCTION , 1986, Transplantation.

[35]  W. Bodmer,et al.  Expression of HLA antigens, β2-microglobulin and enzymes by human amniotic epithelial cells , 1982, Nature.

[36]  S. Leibowitz,et al.  IMMUNOGENICITY OF HUMAN AMNIOTIC EPITHELIAL CELLS AFTER TRANSPLANTATION INTO VOLUNTEERS , 1981, The Lancet.

[37]  A. Sorsby,et al.  AMNIOTIC MEMBRANE GRAFTS IN CAUSTIC BURNS OF THE EYE: (Burns of the second degree). , 1946, British Journal of Ophthalmology.

[38]  A. D. Rötth PLASTIC REPAIR OF CONJUNCTIVAL DEFECTS WITH FETAL MEMBRANES , 1940 .